$EKSO
EKSO BIONICS HOLDINGS, INC.

2018 Q2 Form 10-Q Financial Statement

#000114420418042457 Filed on August 07, 2018

View on sec.gov

Income Statement

Concept 2018 Q2 2017 Q2
Revenue $2.967M $1.867M
YoY Change 58.92% 20.3%
Cost Of Revenue $2.000M $1.471M
YoY Change 35.96% 9.04%
Gross Profit $967.0K $396.0K
YoY Change 144.19% 95.07%
Gross Profit Margin 32.59% 21.21%
Selling, General & Admin $6.760M $5.745M
YoY Change 17.67% 6.82%
% of Gross Profit 699.07% 1450.76%
Research & Development $1.389M $2.632M
YoY Change -47.23% 18.51%
% of Gross Profit 143.64% 664.65%
Depreciation & Amortization $460.0K $400.0K
YoY Change 15.0% -14.89%
% of Gross Profit 47.57% 101.01%
Operating Expenses $8.152M $8.855M
YoY Change -7.94% 16.53%
Operating Profit -$7.185M -$8.459M
YoY Change -15.06% 14.37%
Interest Expense $160.0K $198.0K
YoY Change -19.19% -682.35%
% of Operating Profit
Other Income/Expense, Net -$793.0K $2.952M
YoY Change -126.86% 80.99%
Pretax Income -$7.980M -$5.510M
YoY Change 44.83% -4.51%
Income Tax
% Of Pretax Income
Net Earnings -$7.978M -$5.507M
YoY Change 44.87% -4.48%
Net Earnings / Revenue -268.89% -294.97%
Basic Earnings Per Share
Diluted Earnings Per Share -$1.975M -$3.241M
COMMON SHARES
Basic Shares Outstanding 25.63M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2018 Q2 2017 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $13.89M $10.70M
YoY Change 29.81% 129.61%
Cash & Equivalents $13.89M $10.70M
Short-Term Investments
Other Short-Term Assets $580.0K $600.0K
YoY Change -3.33% -13.04%
Inventory $2.382M $1.896M
Prepaid Expenses
Receivables $3.547M $2.107M
Other Receivables $0.00 $0.00
Total Short-Term Assets $20.40M $15.30M
YoY Change 33.34% 63.3%
LONG-TERM ASSETS
Property, Plant & Equipment $2.271M $2.562M
YoY Change -11.36% -0.7%
Goodwill $189.0K $189.0K
YoY Change 0.0%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $120.0K $118.0K
YoY Change 1.69% 31.11%
Total Long-Term Assets $2.805M $3.631M
YoY Change -22.75% -13.75%
TOTAL ASSETS
Total Short-Term Assets $20.40M $15.30M
Total Long-Term Assets $2.805M $3.631M
Total Assets $23.21M $18.93M
YoY Change 22.59% 39.41%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $2.590M $2.068M
YoY Change 25.24% -0.1%
Accrued Expenses $3.162M $2.458M
YoY Change 28.64% 15.4%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $2.333M $972.0K
YoY Change 140.02% 1115.0%
Total Short-Term Liabilities $9.395M $6.587M
YoY Change 42.63% 13.77%
LONG-TERM LIABILITIES
Long-Term Debt $3.746M $5.906M
YoY Change -36.57%
Other Long-Term Liabilities $36.00K $73.00K
YoY Change -50.68% -98.83%
Total Long-Term Liabilities $3.782M $5.979M
YoY Change -36.75% -3.87%
TOTAL LIABILITIES
Total Short-Term Liabilities $9.395M $6.587M
Total Long-Term Liabilities $3.782M $5.979M
Total Liabilities $15.58M $17.30M
YoY Change -9.95% 44.08%
SHAREHOLDERS EQUITY
Retained Earnings -$160.0M -$128.8M
YoY Change 24.21%
Common Stock $61.00K $26.00K
YoY Change 134.62% 62.5%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $7.626M $1.628M
YoY Change
Total Liabilities & Shareholders Equity $23.21M $18.93M
YoY Change 22.59% 39.41%

Cashflow Statement

Concept 2018 Q2 2017 Q2
OPERATING ACTIVITIES
Net Income -$7.978M -$5.507M
YoY Change 44.87% -4.48%
Depreciation, Depletion And Amortization $460.0K $400.0K
YoY Change 15.0% -14.89%
Cash From Operating Activities -$6.050M -$9.610M
YoY Change -37.04% 31.11%
INVESTING ACTIVITIES
Capital Expenditures $0.00 -$110.0K
YoY Change -100.0% -64.52%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities $0.00 -$110.0K
YoY Change -100.0% -64.52%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -590.0K 10.92M
YoY Change -105.4% -109300.0%
NET CHANGE
Cash From Operating Activities -6.050M -9.610M
Cash From Investing Activities 0.000 -110.0K
Cash From Financing Activities -590.0K 10.92M
Net Change In Cash -6.640M 1.200M
YoY Change -653.33% -115.69%
FREE CASH FLOW
Cash From Operating Activities -$6.050M -$9.610M
Capital Expenditures $0.00 -$110.0K
Free Cash Flow -$6.050M -$9.500M
YoY Change -36.32% 35.33%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
us-gaap Use Of Estimates
UseOfEstimates
<div style="color: rgb(0, 0, 0); font: 10pt &quot;times new roman&quot;, times, serif; letter-spacing: normal; orphans: 2; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; margin: 0px; text-align: justify;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Use of Estimates</div></div></div><div style="color: rgb(0, 0, 0); font: 10pt &quot;times new roman&quot;, times, serif; letter-spacing: normal; orphans: 2; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; margin: 0px; text-align: justify; text-indent: 0.5in; background: none;"><div style="text-decoration: none; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div><div style="color: rgb(0, 0, 0); font: 10pt &quot;times new roman&quot;, times, serif; letter-spacing: normal; orphans: 2; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; margin: 0px; text-align: justify;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">The preparation of the condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the balance sheet, and the reported amounts of revenues and expenses during the reporting period. For the Company, these estimates include, but are not limited to: revenue recognition, deferred revenue and the deferral of the associated costs, future warranty costs, maintenance and planned improvement costs associated with medical device units sold prior to 2016, useful lives assigned to long-lived assets, realizability of deferred tax assets, the valuation of options and warrants, and contingencies. Actual results could differ from those estimates.</div></div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>
CY2018Q2 ekso Accrued Severance
AccruedSeverance
381000 USD
CY2017Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-340000 USD
CY2018Q2 us-gaap Inventory Raw Materials
InventoryRawMaterials
1384000 USD
CY2017Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
1562000 USD
CY2018Q2 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
84000 USD
CY2017Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
212000 USD
CY2018Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
225000 USD
CY2018Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
2043000 USD
CY2017Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
2850000 USD
CY2017Q4 us-gaap Deferred Revenue
DeferredRevenue
1919000 USD
CY2018Q2 us-gaap Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year
LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear
1167000 USD
CY2018Q2 ekso Recognition Of Deferred Revenue Remainder Of Fiscal Year
RecognitionOfDeferredRevenueRemainderOfFiscalYear
552000 USD
CY2018Q2 ekso Recognition Of Deferred Revenue Next Twelve Months
RecognitionOfDeferredRevenueNextTwelveMonths
938000 USD
CY2018Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2017Q4 ekso Accrued Severance
AccruedSeverance
0 USD
CY2018Q2 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
2333000 USD
us-gaap Deferred Revenue Revenue Recognized1
DeferredRevenueRevenueRecognized1
1521000 USD
CY2017Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2018Q2 us-gaap Inventory Work In Process
InventoryWorkInProcess
202000 USD
CY2017Q4 us-gaap Inventory Work In Process
InventoryWorkInProcess
0 USD
us-gaap Oci Before Reclassifications Net Of Tax Attributable To Parent
OciBeforeReclassificationsNetOfTaxAttributableToParent
113000 USD
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div style="color: rgb(0, 0, 0); font: 10pt &quot;times new roman&quot;, times, serif; letter-spacing: normal; orphans: 2; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; margin: 0px; text-align: justify;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Concentration of Credit Risk and Other Risks and Uncertainties</div></div></div><div style="color: rgb(0, 0, 0); font: 10pt &quot;times new roman&quot;, times, serif; letter-spacing: normal; orphans: 2; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; margin: 0px; text-align: justify; text-indent: 0.5in; background: none;"><div style="text-decoration: none; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div><div style="color: rgb(0, 0, 0); font: 10pt &quot;times new roman&quot;, times, serif; letter-spacing: normal; orphans: 2; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; margin: 0px; text-align: justify;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">Financial instruments that potentially subject the Company to concentrations of credit risk consist principally of cash and accounts receivable. The Company maintains its cash accounts in excess of federally insured limits. However, the Company believes it is not exposed to significant credit risk due to the financial position of the depository institutions in which these deposits are held. The Company extends credit to customers in the normal course of business and performs ongoing credit evaluations of its customers. Concentrations of credit risk with respect to accounts receivable exist to the full extent of amounts presented in the condensed consolidated financial statements. The Company does not require collateral from its customers to secure accounts receivable.</div></div><div style="color: rgb(0, 0, 0); font: 10pt &quot;times new roman&quot;, times, serif; letter-spacing: normal; orphans: 2; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; margin: 0px; text-align: justify; background: none;"><div style="text-decoration: none; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div><div style="color: rgb(0, 0, 0); font: 10pt &quot;times new roman&quot;, times, serif; letter-spacing: normal; orphans: 2; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; margin: 0px; text-align: justify;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">Accounts receivable are derived from the sale of products shipped to and services performed for customers. Invoices are aged based on contractual terms with the customer. The Company reviews accounts receivable for collectability and records an allowance for credit losses, as needed. The Company has not experienced any material losses related to accounts receivable as of June 30, 2018 and December 31, 2017.</div></div><div style="color: rgb(0, 0, 0); font: 10pt &quot;times new roman&quot;, times, serif; letter-spacing: normal; orphans: 2; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; margin: 0px; text-align: justify; background: none;"><div style="text-decoration: none; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div><div style="color: rgb(0, 0, 0); font: 10pt &quot;times new roman&quot;, times, serif; letter-spacing: normal; orphans: 2; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; margin: 0px; text-align: justify;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">Many of the sales contracts with customers outside of the U.S. are settled in a foreign currency. The Company does not enter into any foreign currency hedging agreements and is susceptible to gains and losses from foreign currency fluctuations. To date, the Company has not experienced significant gains or losses upon settling foreign currency denominated accounts receivable.</div></div><div style="color: rgb(0, 0, 0); font: 10pt &quot;times new roman&quot;, times, serif; letter-spacing: normal; orphans: 2; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; margin: 0px; text-align: justify; background: none;"><div style="text-decoration: none; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div><div style="color: rgb(0, 0, 0); font: 10pt &quot;times new roman&quot;, times, serif; letter-spacing: normal; orphans: 2; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; margin: 0px; text-align: justify;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">As of June 30, 2018, the Company had no customers with an accounts receivable balance totaling 10% or more of the Company’s total accounts receivable compared with one customer as of December 31, 2017 (10%).</div></div><div style="color: rgb(0, 0, 0); font: 10pt &quot;times new roman&quot;, times, serif; letter-spacing: normal; orphans: 2; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; margin: 0px; text-align: justify; background: none;"><div style="text-decoration: none; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div><div style="color: rgb(0, 0, 0); font: 10pt &quot;times new roman&quot;, times, serif; letter-spacing: normal; orphans: 2; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; margin: 0px; text-align: justify;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">In the three months ended June 30, 2018, the </div>Company had no customers with sales<div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> of 10% or more of the Company’s total revenue, compared with one customer in the three months ended June 30, 2017 (26%).</div></div><div style="color: rgb(0, 0, 0); font: 10pt &quot;times new roman&quot;, times, serif; letter-spacing: normal; orphans: 2; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; margin: 0px; text-align: justify; background: none;"><div style="text-decoration: none; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div><div style="color: rgb(0, 0, 0); font: 10pt &quot;times new roman&quot;, times, serif; letter-spacing: normal; orphans: 2; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; margin: 0px; text-align: justify;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">In the six months ended June 30, 2018, the Company had no customers with sales comprising 10% or more of our total customer sales, compared with one customer in the six months ended June 30, 2017 (14%).</div></div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>
CY2018Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-227000 USD
CY2018Q2 us-gaap Inventory Finished Goods
InventoryFinishedGoods
796000 USD
CY2017Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
1463000 USD
CY2017Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000 shares
CY2018Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000 shares
CY2018Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
13890000 USD
CY2017Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
27813000 USD
us-gaap Recognition Of Deferred Revenue
RecognitionOfDeferredRevenue
-929000 USD
CY2018Q2 ekso Accrued Maintenance Current
AccruedMaintenanceCurrent
109000 USD
CY2017Q4 ekso Accrued Maintenance Current
AccruedMaintenanceCurrent
121000 USD
CY2017Q4 ekso Product Maintenance Warranty Liabilities Current Noncurrent
ProductMaintenanceWarrantyLiabilitiesCurrentNoncurrent
353000 USD
CY2018Q2 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
2333000 USD
CY2018Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
82.12 pure
CY2017Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
82.12 pure
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
82.12 pure
CY2018Q2 ekso Recognition Of Deferred Revenue In Two Years
RecognitionOfDeferredRevenueInTwoYears
961000 USD
dei Document Type
DocumentType
10-Q
dei Amendment Flag
AmendmentFlag
false
CY2018Q2 us-gaap Deferred Revenue
DeferredRevenue
2511000 USD
CY2018Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0285 pure
CY2017Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0188 pure
CY2018Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
402000 USD
CY2017Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
709000 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1294000 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1105000 USD
CY2018Q2 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Four
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
440000 USD
ekso Product Maintenance Warranty Addition
ProductMaintenanceWarrantyAddition
176000 USD
CY2018Q2 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
311000 USD
CY2017Q4 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
232000 USD
CY2018Q2 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
1610000 USD
CY2018Q2 us-gaap Deferred Revenue
DeferredRevenue
2511000 USD
CY2018Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
3547000 USD
CY2017Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
2760000 USD
CY2018Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2017Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2018Q2 us-gaap Inventory Net
InventoryNet
2382000 USD
CY2017Q4 us-gaap Inventory Net
InventoryNet
3025000 USD
CY2018Q2 us-gaap Deferred Rent Credit
DeferredRentCredit
40000 USD
CY2017Q4 us-gaap Deferred Rent Credit
DeferredRentCredit
73000 USD
CY2018Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2017Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2018Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
1385000 USD
CY2018Q2 ekso Accrued Clinical Cost Current
AccruedClinicalCostCurrent
212000 USD
CY2017Q4 ekso Accrued Clinical Cost Current
AccruedClinicalCostCurrent
136000 USD
ekso Product Maintenance Warranty Expense
ProductMaintenanceWarrantyExpense
109000 USD
CY2018Q2 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
6273000 USD
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
0.0188 pure
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
0.027 pure
CY2018Q2 us-gaap Revenues
Revenues
2967000 USD
CY2017Q2 us-gaap Revenues
Revenues
1867000 USD
us-gaap Revenues
Revenues
5486000 USD
us-gaap Revenues
Revenues
3303000 USD
dei Document Period End Date
DocumentPeriodEndDate
2018-06-30
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2018
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
0.0297 pure
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
0.0229 pure
CY2018Q2 us-gaap Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net
DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
-194000 USD
CY2018Q2 ekso Product Maintenance Warranty Liabilities Current Noncurrent
ProductMaintenanceWarrantyLiabilitiesCurrentNoncurrent
420000 USD
CY2018Q2 us-gaap Capital Lease Obligations Current
CapitalLeaseObligationsCurrent
35000 USD
CY2017Q4 us-gaap Capital Lease Obligations Current
CapitalLeaseObligationsCurrent
34000 USD
CY2018Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
225000 USD
CY2018Q2 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
2967000 USD
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
5486000 USD
CY2018Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
584000 USD
CY2017Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1339000 USD
CY2018Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2017Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
2555000 USD
CY2018Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2271000 USD
CY2017Q4 us-gaap Other Intangible Assets Net
OtherIntangibleAssetsNet
491000 USD
ekso Unrestricted Cash
UnrestrictedCash
6524000 USD
CY2018Q2 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
3746000 USD
CY2018Q2 us-gaap Contractual Obligation Due In Next Twelve Months
ContractualObligationDueInNextTwelveMonths
50000 USD
dei Entity Central Index Key
EntityCentralIndexKey
0001549084
CY2018Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
2000000 USD
CY2017Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
1471000 USD
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
3750000 USD
CY2018Q2 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
1310000 USD
CY2017Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
1103000 USD
us-gaap Net Income Loss
NetIncomeLoss
-15877000 USD
us-gaap Net Income Loss
NetIncomeLoss
-13809000 USD
CY2018Q2 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
1201000 USD
CY2017Q4 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
816000 USD
CY2017Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
141429 shares
CY2018Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
141429 shares
CY2018Q2 us-gaap Assets Current
AssetsCurrent
20403000 USD
CY2017Q4 us-gaap Assets Current
AssetsCurrent
34937000 USD
CY2018Q2 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
71000 USD
CY2017Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
130000 USD
CY2018Q2 us-gaap Long Term Debt
LongTermDebt
6079000 USD
CY2017Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Entity Registrant Name
EntityRegistrantName
EKSO BIONICS HOLDINGS, INC.
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.89 pure
CY2018Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.89 pure
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.77 pure
CY2017Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.77 pure
CY2018Q2 us-gaap Long Term Debt Current
LongTermDebtCurrent
2333000 USD
CY2018Q2 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
7366000 USD
CY2017Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2249000 USD
CY2018Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
60832 shares
CY2017Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
59943 shares
us-gaap Depreciation
Depreciation
888000 USD
us-gaap Depreciation
Depreciation
866000 USD
us-gaap Inventory Write Down
InventoryWriteDown
157000 USD
us-gaap Inventory Write Down
InventoryWriteDown
0 USD
CY2018Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
60832 shares
CY2017Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
59943 shares
CY2018Q2 us-gaap Other Intangible Assets Net
OtherIntangibleAssetsNet
225000 USD
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2018Q2 us-gaap Cost Of Revenue
CostOfRevenue
2000000 USD
CY2017Q2 us-gaap Cost Of Revenue
CostOfRevenue
1471000 USD
us-gaap Cost Of Revenue
CostOfRevenue
3750000 USD
us-gaap Cost Of Revenue
CostOfRevenue
2555000 USD
CY2018Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
6390000 shares
CY2017Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
7629000 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
6390000 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
7629000 shares
CY2018Q2 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
317000 USD
CY2017Q2 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
108000 USD
us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
460000 USD
us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
209000 USD
CY2018Q2 us-gaap Goodwill
Goodwill
189000 USD
CY2017Q4 us-gaap Goodwill
Goodwill
189000 USD
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
-109000 USD
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
55000 USD
CY2018Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
120000 USD
CY2017Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
122000 USD
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
7786000 USD
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
6337000 USD
CY2018Q2 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
3933000 USD
CY2017Q2 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
3270000 USD
CY2016Q4 ekso Success Fee Expenses
SuccessFeeExpenses
250000 USD
us-gaap Gross Profit
GrossProfit
1736000 USD
us-gaap Gross Profit
GrossProfit
748000 USD
CY2018Q2 us-gaap Gross Profit
GrossProfit
967000 USD
CY2017Q2 us-gaap Gross Profit
GrossProfit
396000 USD
dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-54000 USD
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
0 USD
dei Trading Symbol
TradingSymbol
EKSO
CY2016Q4 us-gaap Share Price
SharePrice
8.00
CY2018Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1389000 USD
CY2017Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2632000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
3197000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
5505000 USD
CY2018Q2 us-gaap Assets
Assets
23208000 USD
CY2017Q4 us-gaap Assets
Assets
37988000 USD
ekso Gain Loss On Warrant Liability
GainLossOnWarrantLiability
520000 USD
ekso Gain Loss On Warrant Liability
GainLossOnWarrantLiability
3037000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
1294000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
1105000 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
6564000 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
5016000 USD
CY2018Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2827000 USD
CY2017Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2475000 USD
CY2018Q2 ekso Contingent Success Fee Liability
ContingentSuccessFeeLiability
41000 USD
CY2018Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
60832346 shares
CY2018Q2 us-gaap Restructuring Costs
RestructuringCosts
0 USD
CY2017Q2 us-gaap Restructuring Costs
RestructuringCosts
665000 USD
us-gaap Restructuring Costs
RestructuringCosts
0 USD
us-gaap Restructuring Costs
RestructuringCosts
665000 USD
CY2017Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
3396000 shares
CY2018Q2 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
3396000 shares
us-gaap Accretion Expense
AccretionExpense
45000 USD
us-gaap Accretion Expense
AccretionExpense
48000 USD
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
39000 USD
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
41000 USD
CY2018Q2 ekso Change In Fair Value Contingent Liabilities
ChangeInFairValueContingentLiabilities
-3000 USD
CY2017Q2 ekso Change In Fair Value Contingent Liabilities
ChangeInFairValueContingentLiabilities
187000 USD
ekso Change In Fair Value Contingent Liabilities
ChangeInFairValueContingentLiabilities
15000 USD
ekso Change In Fair Value Contingent Liabilities
ChangeInFairValueContingentLiabilities
175000 USD
CY2018Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
2590000 USD
CY2017Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
2420000 USD
ekso Class Of Warrant Or Right Issued
ClassOfWarrantOrRightIssued
0 shares
CY2017Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
3503000 USD
CY2018Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-7185000 USD
ekso Class Of Warrant Or Right Expired
ClassOfWarrantOrRightExpired
0 shares
CY2018Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
3162000 USD
CY2017Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-8459000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-15796000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-16600000 USD
ekso Gain Loss On Change In Fair Value Contingent Liabilities
GainLossOnChangeInFairValueContingentLiabilities
17000 USD
ekso Gain Loss On Change In Fair Value Contingent Liabilities
GainLossOnChangeInFairValueContingentLiabilities
58000 USD
ekso Common Stock Contribution
CommonStockContribution
118000 USD
ekso Common Stock Contribution
CommonStockContribution
0 USD
CY2018Q2 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
1310000 USD
CY2017Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
1103000 USD
CY2018Q2 us-gaap Debt Instrument Interest Rate During Period
DebtInstrumentInterestRateDuringPeriod
0.0997 pure
us-gaap Debt Instrument Interest Rate During Period
DebtInstrumentInterestRateDuringPeriod
0.0982 pure
CY2018Q2 us-gaap Notes Payable Current
NotesPayableCurrent
2333000 USD
CY2017Q4 us-gaap Notes Payable Current
NotesPayableCurrent
2139000 USD
us-gaap Interest Expense
InterestExpense
324000 USD
us-gaap Interest Expense
InterestExpense
316000 USD
CY2018Q2 us-gaap Interest Expense
InterestExpense
160000 USD
CY2017Q2 us-gaap Interest Expense
InterestExpense
198000 USD
us-gaap Foreign Currency Transaction Gain Loss Unrealized
ForeignCurrencyTransactionGainLossUnrealized
-234000 USD
us-gaap Foreign Currency Transaction Gain Loss Unrealized
ForeignCurrencyTransactionGainLossUnrealized
273000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
678000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
382000 USD
CY2018Q2 ekso Gain Loss On Warrant Liability
GainLossOnWarrantLiability
-213000 USD
CY2017Q2 ekso Gain Loss On Warrant Liability
GainLossOnWarrantLiability
3106000 USD
ekso Gain Loss On Warrant Liability
GainLossOnWarrantLiability
520000 USD
ekso Gain Loss On Warrant Liability
GainLossOnWarrantLiability
3037000 USD
CY2018Q2 us-gaap Liabilities Current
LiabilitiesCurrent
9395000 USD
CY2017Q4 us-gaap Liabilities Current
LiabilitiesCurrent
9165000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
198000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
836000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-757000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
122000 USD
CY2018Q2 us-gaap Long Term Notes Payable
LongTermNotesPayable
3746000 USD
CY2017Q4 us-gaap Long Term Notes Payable
LongTermNotesPayable
4830000 USD
CY2018Q2 ekso Other Income Expense
OtherIncomeExpense
-420000 USD
CY2017Q2 ekso Other Income Expense
OtherIncomeExpense
44000 USD
ekso Other Income Expense
OtherIncomeExpense
-277000 USD
ekso Other Income Expense
OtherIncomeExpense
70000 USD
CY2018Q2 us-gaap Derivative Liabilities
DerivativeLiabilities
1128000 USD
CY2017Q4 us-gaap Derivative Liabilities
DerivativeLiabilities
1648000 USD
CY2018Q2 us-gaap Net Income Loss
NetIncomeLoss
-7978000 USD
CY2017Q2 us-gaap Net Income Loss
NetIncomeLoss
-5507000 USD
us-gaap Net Income Loss
NetIncomeLoss
-15877000 USD
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
113000 USD
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-234000 USD
CY2018Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
320000 USD
CY2017Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-203000 USD
CY2018Q2 us-gaap Business Combination Contingent Consideration Liability Noncurrent
BusinessCombinationContingentConsiderationLiabilityNoncurrent
76000 USD
CY2017Q4 us-gaap Business Combination Contingent Consideration Liability Noncurrent
BusinessCombinationContingentConsiderationLiabilityNoncurrent
81000 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
210000 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
328000 USD
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
215000 USD
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-851000 USD
CY2018Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
36000 USD
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
60386000 shares
CY2017Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
57000 USD
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
23717000 shares
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-12804000 USD
CY2018Q2 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2017Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-16859000 USD
us-gaap Stock Issued During Period Shares Employee Benefit Plan
StockIssuedDuringPeriodSharesEmployeeBenefitPlan
221000 shares
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
31000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
248000 USD
CY2018Q2 us-gaap Common Stock Value
CommonStockValue
61000 USD
CY2017Q4 us-gaap Common Stock Value
CommonStockValue
60000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-31000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-248000 USD
CY2018Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
167823000 USD
CY2017Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
165825000 USD
ekso Proceeds From Issuance Of Common Stock Preference Stock And Warrants
ProceedsFromIssuanceOfCommonStockPreferenceStockAndWarrants
0 USD
ekso Proceeds From Issuance Of Common Stock Preference Stock And Warrants
ProceedsFromIssuanceOfCommonStockPreferenceStockAndWarrants
10919000 USD
CY2018Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-160031000 USD
CY2017Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-144154000 USD
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
994000 USD
CY2018Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
60621000 shares
CY2017Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
25515000 shares
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
38000 USD
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
0 USD
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
42000 USD
CY2018Q2 us-gaap Stockholders Equity
StockholdersEquity
7626000 USD
CY2017Q4 us-gaap Stockholders Equity
StockholdersEquity
21391000 USD
CY2018Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
23208000 USD
CY2017Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
37988000 USD
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
-94000 USD
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
39000 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-13923000 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-6145000 USD
CY2018Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-7658000 USD
CY2017Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-5710000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-15764000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-14043000 USD
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.26
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.58
CY2018Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.13
CY2017Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.22
CY2018Q2 us-gaap Liabilities
Liabilities
15582000 USD
CY2017Q4 us-gaap Liabilities
Liabilities
16597000 USD
CY2017 us-gaap Defined Contribution Plan Employer Matching Contribution Percent Of Match
DefinedContributionPlanEmployerMatchingContributionPercentOfMatch
1 pure
us-gaap Increase Decrease In Restructuring Reserve
IncreaseDecreaseInRestructuringReserve
0 USD
us-gaap Increase Decrease In Restructuring Reserve
IncreaseDecreaseInRestructuringReserve
95000 USD
CY2017 ekso Defined Contribution Plan Maximum Annual Contributions Percentagethereafter
DefinedContributionPlanMaximumAnnualContributionsPercentagethereafter
0.5 pure
CY2018Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2017Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2016Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
16846000 USD
CY2017Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
10701000 USD
ekso Transfer Of Property And Equipment From Inventory
TransferOfPropertyAndEquipmentFromInventory
684000 USD
ekso Transfer Of Property And Equipment From Inventory
TransferOfPropertyAndEquipmentFromInventory
496000 USD
ekso Shares Issued Capital Contribution
SharesIssuedCapitalContribution
508000 USD
ekso Shares Issued Capital Contribution
SharesIssuedCapitalContribution
0 USD
us-gaap Stock Issued1
StockIssued1
230000 USD
us-gaap Stock Issued1
StockIssued1
0 USD
ekso Sales Earnout
SalesEarnout
28000 USD
ekso Sales Earnout
SalesEarnout
47000 USD
ekso Supply Earn Out
SupplyEarnOut
0 USD
ekso Supply Earn Out
SupplyEarnOut
189000 USD
us-gaap Operating Expenses
OperatingExpenses
17532000 USD
us-gaap Operating Expenses
OperatingExpenses
17348000 USD
CY2018Q2 us-gaap Operating Expenses
OperatingExpenses
8152000 USD
CY2017Q2 us-gaap Operating Expenses
OperatingExpenses
8855000 USD
us-gaap Income Taxes Paid
IncomeTaxesPaid
238000 USD
us-gaap Income Taxes Paid
IncomeTaxesPaid
188000 USD
us-gaap Interest Paid Net
InterestPaidNet
0 USD
us-gaap Interest Paid Net
InterestPaidNet
2000 USD
ekso Cumulative Retrospective Adjustment To Retained Earnings
CumulativeRetrospectiveAdjustmentToRetainedEarnings
0 USD
ekso Cumulative Retrospective Adjustment To Retained Earnings
CumulativeRetrospectiveAdjustmentToRetainedEarnings
171000 USD
ekso Warrant Issuance
WarrantIssuance
0 USD
ekso Warrant Issuance
WarrantIssuance
3301000 USD
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
584000 USD
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-29000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-994000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
10923000 USD
CY2018Q2 us-gaap Contractual Obligation
ContractualObligation
936000 USD
CY2018Q2 us-gaap Lessee Operating Lease Renewal Term
LesseeOperatingLeaseRenewalTerm
P5Y
CY2018Q2 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
2967000 USD
CY2017Q2 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
1867000 USD
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
5486000 USD
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
3303000 USD
CY2018Q2 us-gaap Gross Profit
GrossProfit
967000 USD
us-gaap Gross Profit
GrossProfit
1736000 USD
CY2018Q2 us-gaap Lessee Operating Lease Term Of Contract
LesseeOperatingLeaseTermOfContract
P5Y
ekso Selling And Marketing Expense Relating To Operating Lease Obligations
SellingAndMarketingExpenseRelatingToOperatingLeaseObligations
175000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-81000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
2791000 USD
CY2018Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-793000 USD
CY2017Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
2952000 USD
CY2018Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
60621000 shares
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
23717000 shares
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-13809000 USD
CY2017Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-5507000 USD
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-15877000 USD
CY2018Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-7978000 USD

Files In Submission

Name View Source Status
0001144204-18-042457-index-headers.html Edgar Link pending
0001144204-18-042457-index.html Edgar Link pending
0001144204-18-042457.txt Edgar Link pending
0001144204-18-042457-xbrl.zip Edgar Link pending
ekso-20180630.xml Edgar Link completed
ekso-20180630.xsd Edgar Link pending
ekso-20180630_cal.xml Edgar Link unprocessable
ekso-20180630_def.xml Edgar Link unprocessable
ekso-20180630_lab.xml Edgar Link unprocessable
ekso-20180630_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
tv499418_10q.htm Edgar Link pending
tv499418_ex10-3.htm Edgar Link pending
tv499418_ex31-1.htm Edgar Link pending
tv499418_ex31-2.htm Edgar Link pending
tv499418_ex32-1.htm Edgar Link pending
tv499418_ex32-2.htm Edgar Link pending